Tm. Fishbein et al., National sharing of cadaveric isolated intestinal allografts for human transplantation: A feasibility study, TRANSPLANT, 69(5), 2000, pp. 859-863
Most isolated intestinal graft losses are immunological, We conducted a pil
ot, study to evaluate the feasibility of national sharing of HLA no-mismatc
h allografts for cadaveric isolated intestinal transplantation.
Methods. UNOS data were analyzed in a theoretical model. Part I: All solid
organ donors between 1/95-8/97 who would have met criteria for bowel donati
on were considered potential donors for all recipients who actually receive
d isolated intestinal transplants during this period. We then determined ho
w many donor intestines could have been directed to no-mismatch candidates
had national sharing been in place. Donor exclusion criteria were (CMV+ don
ors to CMV- recipients, hemodynamic instability, age >50, size mismatch (do
nor weight greater than recipient), and obesity. Mean and median waits for
transplants, as well as theoretical mean and median waits for transplants t
hat would have occurred given national sharing, were calculated. Part II: W
e estimated, based on registry graft survival dar;a, the number of intestin
al transplants necessary to demonstrate a no-mismatch graft survival advant
age! at 2 years.
Results, Part I: Although no actual cadaveric no-mismatch transplant was pe
rformed, 12-17% of patients could have received no-mismatch allografts had
sharing been in place, using various donor acceptance criteria. The impact
on waiting time was variable. Part II: Accepting a 15% rate of no mismatch
cases and a survival advantage of 10% at 2 years, 793 transplants would be
required to prove an advantage to HLA matching at P<0.05, If the graft surv
ival advantage were 20% at 2 years, the time to show significance would be
approximately 5 years. Using early acute rejection as an endpoint could req
uire fewer transplants (93), and only a few years to complete the study.
Conclusions. National sharing of cadaveric isolated intestinal allografts i
s feasible. Median waits would not be significantly increased. The time nec
essary to prove graft survival advantage would be considerable, but a diffe
rence in the rate of acute rejection could be seen within 2 years. Addition
ally, a national sharing arrangement might improve the overall outcome of i
solated intestinal transplantation.